이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Imagery-based Coping for Cocaine Use Disorder (CIIC)

2019년 2월 26일 업데이트: King's College London

Clinical Study of Imagery-based Coping for Cocaine Use Disorder

A pragmatic, 4-week, 4-group, between-subjects, factorial randomised controlled trial conducted at a specialist NHS outpatient addictions clinic and hospital clinical research facility to determine if mental imagery (of past and future positive [recovery oriented] and negative [cocaine aversive] events) can help reduce cue-induced cocaine craving and cocaine use.

연구 개요

상태

알려지지 않은

상세 설명

Cocaine, a powerful stimulant drug, is used by 2.2% of people aged 16-59 in England and each year about 150.000 people seek help for cocaine use disorder from the NHS or non-governmental organisations (NGO). There are currently no approved medication-assisted treatments or specific psychosocial interventions for CUD. General counselling is offered by the NHS and NGO addiction services, but this is not particularly effective.

The transition from regular cocaine use to cocaine abuse is often marked by intense episodes (binges), which may last several days and are followed by a 'crash' with no or little use. For many people, repeated administration of cocaine over a short duration of time creates vivid episodic memories of euphoria which can inform future craving content. Craving or strong urges are a distinctive feature of CUD and are often reported as involuntary, distressing and uncontrollable.

Research has demonstrated that craving experiences can be voluntarily evoked or elicited by conditioned drug cues in the environment and internal processes such mood or physical sensations. The associations between cues and use are established through classical and instrumental reward-based conditioning and are important for the development and maintenance of CUD. Enhanced attention to cocaine cues develops and remains heightened for at least six months into abstinence.

Craving-related experiences are informed by memories of intense reward, physical sensations and include pro-drug beliefs, appraisals, expectancies and vivid mental imagery. Drug-imagery is often initially pleasurable and affectively charged and can motivate drug-seeking behaviour. If impeded or delayed, drug imagery highlights a deficit and can be experienced as distressing and intrusive. Treatment of intrusive images has been successful in various psychological disorders using imagery rescripting. Imagery rescripting has recently been used in memory-focused cognitive therapy to help reduce cocaine craving. Reducing intrusive image-induced negative affect through positive imagery is important for relieving psychological distress but there is also evidence that aversive imagery may reduce maladaptive approach behaviours.

This will be a pragmatic, 4-week, 2x2, between-subjects, factorial randomised controlled trial. It will be conducted at a specialist NHS outpatient addictions clinic (Lorraine Hewitt House; LHH) operated by South London and Maudsley NHS Foundation trust (SLaM) and at the NIHR Wellcome Trust King's Clinical Research Facility (CRF) at King's College Hospital.

Informed consenting adult participants will be randomised to one of four conditions:

  • future-based (prospective) recovery-oriented imagery;
  • future-based (prospective) cocaine-aversive imagery;
  • past (autobiographical) recovery-oriented imagery; or
  • past (autobiographical) cocaine-aversive imagery.

Participants will undergo a craving induction procedure designed to elicit cue-induced craving. In response to elevated craving, participants will be asked to reduce their craving levels using a mental imagery intervention.

Following the procedure in the research facility, participants will be given a digital audio player to take home. This will contain a recording of the imagery condition they are allocated to. Participants will be asked to listen to this recording each day during a 14-day follow-up, and ad libertatem when experiencing cocaine craving. After 14 days participants will be invited for a follow up conducted at the community addictions clinic.

연구 유형

중재적

등록 (예상)

120

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 연락처

연구 연락처 백업

연구 장소

      • London, 영국, SW9 8DG
        • 모병
        • Lorraine Hewitt House
        • 연락하다:

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Adult (18 years and over; no upper limit);
  • English speaking (to a level sufficient to engage with a psychosocial intervention);
  • Current diagnosis for primary CUD alone, with concurrent opiate use disorder or while enrolled in opioid agonist therapy *
  • Self-reported regular use of crack cocaine;
  • Stated motivation to reduce or quit cocaine use;

Exclusion Criteria:

  • Current post-traumatic stress disorder (PTCI score >100);
  • Suicide attempt in the past 3 months;
  • Participants with harmful alcohol consumption (>50 units per week men; >35 units women);
  • Cocaine hydrochloride (powder form) users; **
  • Non-English Speaking;
  • Clinically significant on-going medical problems that might make participation unsafe;
  • Uncontrolled Mental Health Disorder;
  • Severe neurocognitive impairment (Montreal Cognitive Assessment <17);
  • Current enrolment in an addiction treatment related clinical research study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Future-based recovery-oriented imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a future without cocaine use
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
실험적: Future-based cocaine-aversive imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a future where cocaine is causing significant distress
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
실험적: Past recovery-oriented imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a past event without cocaine use
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder
실험적: Past cocaine-aversive imagery
Mental Imagery for Craving Reduction: mental imagery aimed at describing a past event where cocaine use has caused significant distress
a behavioural mental imagery intervention where participants are asked to generate specific mental images to reduce cue-induced craving for cocaine use disorder

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Changes in Number of Days abstinent from Cocaine
기간: baseline (Week 0) and at two week-follow up (Week 4)

The primary outcome measure will be number of days abstinent from cocaine (percentage). A higher percentage indicates a higher number of abstinent days from cocaine.

This will be expressed as the cumulative distribution function for change (between baseline and follow-up) using a Timeline Follow Back method (calendar prompt).

Percentage days abstinent is measured for two weeks before the first assessment and two weeks post craving-induction procedure.

baseline (Week 0) and at two week-follow up (Week 4)

2차 결과 측정

결과 측정
측정값 설명
기간
Change from baseline in Craving Experience Questionnaire Score (CEQ-12)
기간: baseline (Week 0) and at two week-follow up (Week 4)

The CEQ-12 is an 12-item, self-report instrument measuring intensity, imagery and intrusiveness dimensions of craving. Each item is rated on a 11-point scale (0-10), ranging from 0-120, where a higher score expresses increased craving.

The intensity subscale ranges from 0 to 30 where 30 indicates a constant urge to use cocaine.

The imagery subscale ranges from 0 to 60 where 60 indicates a constant sensory craving experience The intrusiveness subscale ranges from 0 to 30 where 30 indicates constant intrusive thoughts about cocaine

The CEQ-12 is measured at baseline (craving for past 2 weeks) and at two week-follow up (craving for past two weeks)

The total craving score will be expressed as cumulative distribution function for change in cocaine craving.

baseline (Week 0) and at two week-follow up (Week 4)
Urine toxicology Screening (UDS)
기간: Assessed at two-week follow up (Week 4)
By instant result immunoassay device for cocaine metabolite (benzoylecgonine) and morphine (Alere Toxicology).
Assessed at two-week follow up (Week 4)
Imagery Monitoring Diary
기간: Diary assessed at two-week follow up (Week 4)
A monitoring diary used by participants to indicate use of guided imagery audio and changes in craving levels. Diary will be used daily throughout 14-day follow-up period.
Diary assessed at two-week follow up (Week 4)
Heart Rate Variability (HRV)
기간: Week 2; 2 hour session
Real-time HRV data will be acquired through an E4 Empatica (www.empatica.com) wristband placed on the participants' wrist during the craving induction procedure and imagery intervention conducted at the clinical research facility. the HRV is derived from blood volume pulse and will be computed using the mean differences and peak values of the parameters.
Week 2; 2 hour session
Electrodermal Activity (EDA)
기간: Week 2; 2 hour session
Real-time EDA data will be acquired through an E4 Empatica (www.empatica.com) wristband placed on the participants' wrist during the craving induction procedure and imagery intervention conducted at the clinical research facility. the EDA will be computed using the mean differences and peak values of the parameters.
Week 2; 2 hour session
Temperature
기간: Week 2; 2 hour session
Real-time EDA data will be acquired through an E4 Empatica (www.empatica.com) wristband placed on the participants' wrist during the craving induction procedure and imagery intervention conducted at the clinical research facility. the EDA will be computed using the mean differences and peak values of the parameters.
Week 2; 2 hour session
Episodic Foresight Score (EFS)
기간: EFS is assessed during the assessment session (Week 1)

based on the Adapted Autobiographical Interview (AI (Levine et al. 2002; adapted version, Addis, Wong and Schacter (2008)); adapted for this study. The Episodic foresight score (EFS) provides an index of the extent to which participants are personally experiencing an event during mental imagining. This translates into episodic foresight capabilities.

EFS is derived from transcribed mental image descriptions. Details are segmented and categorised as either internal or external. The number of internal details provided an index of the extent to which participants are personally experiencing the event during mental imagining.

High score of external details/ Low score of internal detail signify limited episodic foresight whereas a low score of external detail/high score of internal detail signifies good episodic foresight.

EFS is assessed during the assessment session (Week 1)
Substance Related Imagery Semi Structured Interview (SRI)
기간: Week 1 (Assessment)

A semi structured interview examining intrusive imagery in substance use. This interview will be used to explore individual craving experiences and help prepare the participant for the imagery intervention.

Consists of 21 questions exploring imagery in substance use. These are divided into three sections: Exploring Substance Related Images, Link to memories and Negative Valence Imagery.

Interview consists of a mix of open-ended questions, visual analogue scales and Yes/No questions.

The interview schedule will be used during the craving experiences interview in the stage 1 assessment.

Week 1 (Assessment)
Predominance of verbal and imagery-based thoughts visual analogue scale (PV-IT)
기간: Week 2 ( x2; Post Craving Induction; Post Imagery Intervention)

Consists of two rating questions to assess the use of imagery versus verbal thought;

'How much of the time has your thinking taken the form of verbal thoughts over the past 5 minutes?', 'How much of the time has your thinking taken the form of mental imagery over the past 5 minutes?',

along with two analogue scales ranging from 'none of the time' to 'all of the time', from 0-9 where 9 indicates all of the time. A higher score indicates frequency of thought in either a visual or verbal modality.

Scale will be administered post craving induction procedure and post imagery intervention.

Week 2 ( x2; Post Craving Induction; Post Imagery Intervention)
The Positive and Negative affect Schedule (PANAS)
기간: Week 2 ( Post Imagery Intervention)

A self-report questionnaire to measure positive and negative affect. The PANAS consists of 20 different affect-related words. Participants indicate if and to what extent they experience the described feeling at the moment of filling in the questionnaire. The scale ranges from 1-5, where 5 indicates a strong experience of a feeling whereas 1 indicates very slightly or not at all.

The PANAS provides two scores, one for negative affect and one for positive affect, where higher scores indicate higher levels of negative and positive affect respectively.

The PANAS will be administered post imagery intervention.

Week 2 ( Post Imagery Intervention)
Obsessive Compulsive Drug Use Scale (OCDUS)
기간: Week 1 ( Assessment)

A self-report questionnaire to measure craving with a focus on the intrusive, obsessive and compulsive characteristics associated to cocaine craving and use.

The OCDUS has 12 questions rated on a 1-5 Likert Scale and is divided into three subscales: Cocaine Thoughts and Interference (six items), Desire and Control (four items); Resistance to Thoughts and Intention (two items).

High scores indicate high levels of cocaine thoughts and interference, high levels of desire and low control over cocaine use and low levels of resistance to cocaine thoughts.

Questionnaire will be administered during Stage 1 assessment.

Week 1 ( Assessment)
Patient Health Questionnaire (PHQ-9)
기간: Week 1 (Assessment)

A self-administered questionnaire to assess depression severity using the DSM-IV depression criteria. The PHQ-9 consists of 9 items rated on a 4 point scale ( 0-3). The PHQ-9 explores the frequency of problems over the last two weeks where 0 is not at all and 3 is nearly every day.

The total score indicates depression severity as follows: 0-4 none, 5-9 mild, 10-14 moderate, 15-19 moderately severe, 20-27 severe.

Questionnaire will be administered during Stage 1 assessment.

Week 1 (Assessment)
Generalised Anxiety Disorder Assessment (GAD-7)
기간: Week 1 (Assessment)

A self-administered questionnaire to assess general anxiety disorder (GAD) using the DSM-IV criteria. The GAD-7 consists of 7 items rated on a 4 point scale ( 0-3). The GAD-7 explores the frequency of problems over the last two weeks where 0 is not at all and 3 is nearly every day.

The total score (0-21) indicates anxiety severity as follows: : 0-5 mild 6-10 moderate 11-15 moderately severe anxiety ;15-21 severe anxiety.

Questionnaire will be administered during Stage 1 assessment.

Week 1 (Assessment)

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: John Marsden, King's College London

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2018년 10월 30일

기본 완료 (예상)

2020년 1월 30일

연구 완료 (예상)

2020년 9월 30일

연구 등록 날짜

최초 제출

2018년 8월 22일

QC 기준을 충족하는 최초 제출

2018년 8월 30일

처음 게시됨 (실제)

2018년 9월 4일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2019년 2월 28일

QC 기준을 충족하는 마지막 업데이트 제출

2019년 2월 26일

마지막으로 확인됨

2018년 8월 1일

추가 정보

이 연구와 관련된 용어

추가 관련 MeSH 약관

기타 연구 ID 번호

  • 18?LO/1013

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

3
구독하다